Adrenergic blockers and the risk for common solid cancers: a case-control study
Laboratory studies have suggested that adrenergic blockers may inhibit the proliferation and migration of cancer cells, but epidemiological evidence of their effect on cancer incidence has proven inconsistent. We therefore conducted a case-control study using the Clinical Practice Research Datalink...
| Main Authors: | Numbere, Beade, Fleming, Kate M., Walker, Alex, Card, Timothy R. |
|---|---|
| Format: | Article |
| Published: |
Lippincott, Williams & Wilkins
2017
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/49399/ |
Similar Items
Can adrenergic blockers prevent or retard the progression of common cancers?
by: Numbere, Beade
Published: (2016)
by: Numbere, Beade
Published: (2016)
Counting the costs of cancer care: breast, cervical and lung cancer in Trent
by: Wolstenholme, Jane
Published: (2001)
by: Wolstenholme, Jane
Published: (2001)
What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?
by: O'Dowd, Emma L., et al.
Published: (2015)
by: O'Dowd, Emma L., et al.
Published: (2015)
Quantifying important risk factors and survival following treatment in people with lung cancer using routinely collected national data
by: Powell, Helen.
Published: (2014)
by: Powell, Helen.
Published: (2014)
Theranostic tools against lung and breast cancers : through the lens of mature gold nanoparticles and emerging graphene
by: Baskaran, Savuntherii, et al.
Published: (2024)
by: Baskaran, Savuntherii, et al.
Published: (2024)
Effects of silencing dishevelled 1, 2 and 3 mRNA expression on MDA-MB-231 cell migration and invasion using siRNAs
by: Khoo, Samuel Leon Juan
Published: (2015)
by: Khoo, Samuel Leon Juan
Published: (2015)
Synthesis of ganoderic acid analogues to investigate their activity as anti-prostate cancer agents
by: Al-Obaidi, Mohammed
Published: (2019)
by: Al-Obaidi, Mohammed
Published: (2019)
Formulation and optimization of nanoemulsion containing gemcitabine for lung cancer treatment
by: Wahgiman, Nadiatul Atiqah
Published: (2019)
by: Wahgiman, Nadiatul Atiqah
Published: (2019)
Anti-cancer actions in commonly used drugs: epidemiology led by laboratory science
by: Walker, Alex J.
Published: (2011)
by: Walker, Alex J.
Published: (2011)
An investigation into entotic behaviour of breast cancer cells
by: ZAILAN, YASMEEN
Published: (2018)
by: ZAILAN, YASMEEN
Published: (2018)
The regulatory role of ELK-1 ubiquitination in cell proliferation and prostate cancer
by: Quintero Barceinas, Reyna Sara
Published: (2020)
by: Quintero Barceinas, Reyna Sara
Published: (2020)
When are breast cancer patients at highest risk of venous thromboembolism: a cohort study using English healthcare data
by: Walker, Alex J., et al.
Published: (2015)
by: Walker, Alex J., et al.
Published: (2015)
Factors affecting recruitment to breast cancer clinical trials: an examination of the British Association of Surgical Oncology II trial and the International Breast Cancer Intervention Study
by: Maslin-Prothero, Sian
Published: (2000)
by: Maslin-Prothero, Sian
Published: (2000)
Passerini multicomponent reaction: a versatile synthesis of nanomedicines for triple negative breast cancer treatment
by: Travanut, Alessandra
Published: (2021)
by: Travanut, Alessandra
Published: (2021)
Polyadenylation as a target for the treatment of breast cancer
by: Thiyab, Asraa
Published: (2025)
by: Thiyab, Asraa
Published: (2025)
Characterization and anti-cancer effects of citral-loaded nanostructured lipid carrier in breast cancer cells in vitro and in vivo
by: Nordin, Noraini
Published: (2017)
by: Nordin, Noraini
Published: (2017)
Fabrication, characterization and functionalization of single-walled carbon nanotube conjugated with tamoxifen and its anticancer potential against human breast cancer cells
by: Oskoueian, Arshin
Published: (2018)
by: Oskoueian, Arshin
Published: (2018)
Effects of ampelopsin E towards the invasiveness of triple negative breast cancer cell line, MDA-MB-231
by: Tieng, Francis Yew Fu
Published: (2019)
by: Tieng, Francis Yew Fu
Published: (2019)
Human rather than mouse mesenchymal stem cells in 3D co-culture models boost proliferative and migratory characteristics of colorectal cancer cells through paracrine signalling pathways, highlighting species disconnects
by: Lu, M.
Published: (2022)
by: Lu, M.
Published: (2022)
Lung cancer diagnosed following an emergency admission: mixed methods study of the management, outcomes and needs and experiences of patients and carers
by: Wilcock, Andrew, et al.
Published: (2016)
by: Wilcock, Andrew, et al.
Published: (2016)
Prognostic significance of tissue-resident CD8+ T cells
in breast cancer: an African population
by: Field, Lara
Published: (2022)
by: Field, Lara
Published: (2022)
eIF4A2 is a regulator of hypoxic translation and colorectal tumour cell survival
by: Bolland, Hannah
Published: (2020)
by: Bolland, Hannah
Published: (2020)
Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England
by: Walker, A.J., et al.
Published: (2014)
by: Walker, A.J., et al.
Published: (2014)
Identification of differentially regulated genes in breast (MCF-7) and lung (H1299) cancer cell lines during Newcastle disease virus strain AF2240 infection
by: Roslan, Nurhidayah
Published: (2012)
by: Roslan, Nurhidayah
Published: (2012)
The role of the community pharmacist in breast cancer survivorship services
by: Tutt, Lydia
Published: (2020)
by: Tutt, Lydia
Published: (2020)
Microbiota profile of Malaysian kefir grain and anti-metastatic effects of kefir water in murine breast cancer cells
by: Zamberi, Nur Rizi
Published: (2016)
by: Zamberi, Nur Rizi
Published: (2016)
PIK3C Agene mutations in breast carcinoma in Malaysian patients
by: Leong, Vincent Ching-Shian, et al.
Published: (2008)
by: Leong, Vincent Ching-Shian, et al.
Published: (2008)
High nuclear MSK1 is associated with longer survival in breast cancer patients
by: Pu, Xuan, et al.
Published: (2018)
by: Pu, Xuan, et al.
Published: (2018)
Developing a religious program for breast cancer survivors
by: Alwi, Khadijah, et al.
Published: (2007)
by: Alwi, Khadijah, et al.
Published: (2007)
Building an ex vivo model of breast cancer lung metastasis
by: Grey, James F.E.
Published: (2019)
by: Grey, James F.E.
Published: (2019)
Anti-breast cancer effect of eupatorin in vitro and in vivo
by: Abd Razak, Nursyamirah
Published: (2018)
by: Abd Razak, Nursyamirah
Published: (2018)
Investigating the role of Cten in metastatic colorectal cancer
by: Thorpe, Hannah
Published: (2016)
by: Thorpe, Hannah
Published: (2016)
An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
by: Candido Dos Reis, Francisco J., et al.
Published: (2017)
by: Candido Dos Reis, Francisco J., et al.
Published: (2017)
Characterisation of Induced Rat Mammary Gland Tumor and the Antitumor Effect of Recombinant Human Erythropoietin and Tamoxifen
by: Abdul Karim, Sairah
Published: (2009)
by: Abdul Karim, Sairah
Published: (2009)
Anti-breast cancer effect and molecular mechanism of action of artonin e using In Silico, In Vitro and In Vivo approaches
by: Etti, Imaobong Christopher
Published: (2016)
by: Etti, Imaobong Christopher
Published: (2016)
Molecular and Cytoskeletal Changes in Breast Cancer Cell Lines Treated With Newcastle Disease Virus Strain Af2240
by: Eshak, Zolkapli
Published: (2006)
by: Eshak, Zolkapli
Published: (2006)
Cellular Apoptosis of 4T1 Breast Cancer Cells Induced By V4-UPM Newcastle Disease Virus
by: Mahadi, Mahani
Published: (2007)
by: Mahadi, Mahani
Published: (2007)
Construction of a Single Chain Variable Fragment Against Mcf-7 Breast Cancer Cells
by: Ahmad, Zuhaida Asra
Published: (2008)
by: Ahmad, Zuhaida Asra
Published: (2008)
Morphological and Molecular Characterisation of Ethanolic Neem (Azadirachta Indica) Leaf Extract In an in Vivo Breast Cancer Model
by: Lam, Tsuey Peng
Published: (2007)
by: Lam, Tsuey Peng
Published: (2007)
Effects of disrupting insulin-like growth factor-1 receptor (IGF-1R) signal transduction pathways with inhibitors of IGF-1R, EGFR, PI3K, MEK, and MTOR in breast cancer cell lines
by: Ayub, Ayunadirah
Published: (2014)
by: Ayub, Ayunadirah
Published: (2014)
Similar Items
-
Can adrenergic blockers prevent or retard the progression of common cancers?
by: Numbere, Beade
Published: (2016) -
Counting the costs of cancer care: breast, cervical and lung cancer in Trent
by: Wolstenholme, Jane
Published: (2001) -
What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?
by: O'Dowd, Emma L., et al.
Published: (2015) -
Quantifying important risk factors and survival following treatment in people with lung cancer using routinely collected national data
by: Powell, Helen.
Published: (2014) -
Theranostic tools against lung and breast cancers : through the lens of mature gold nanoparticles and emerging graphene
by: Baskaran, Savuntherii, et al.
Published: (2024)